Publicacións nas que colabora con LUIS ORTEGA MEDINA (9)

2024

  1. Preoperative liver regeneration with CD133+ infusion in patients with colorectal liver metastases: proof-of concept trial

    HPB

2021

  1. Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma

    Annals of Diagnostic Pathology, Vol. 53

2020

  1. CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial

    Surgical Oncology, Vol. 33, pp. 224-230

  2. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)

    Clinical and Translational Oncology, Vol. 22, Núm. 7, pp. 1180-1186

  3. The clinical significance of PIWIL3 and PIWIL4 expression in pancreatic cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 5

2019

  1. Still a place for conventional histopathological analysis in the era of molecular medicine: predicting prognosis of resectable ductal pancreatic adenocarcinoma

    Clinical and Translational Oncology, Vol. 21, Núm. 7, pp. 954-959

  2. The prognosis value of PIWIL1 and PIWIL2 expression in pancreatic cancer

    Journal of Clinical Medicine, Vol. 8, Núm. 9

2013

  1. Dissemination of hepatocellular carcinoma in subcutaeous tissue after fine needle aspiration cytology (FNAC)

    Hepato-Gastroenterology, Vol. 60, Núm. 128, pp. 1839-1840

2006

  1. Epithelioid hemangioendothelioma of the liver

    Journal of Hepato-Biliary-Pancreatic Surgery, Vol. 13, Núm. 2, pp. 167-171